Your browser is no longer supported. Please, upgrade your browser.
Settings
ENDP Endo International plc daily Stock Chart
ENDP [NASD]
Endo International plc
Index- P/E- EPS (ttm)-14.81 Insider Own0.20% Shs Outstand222.37M Perf Week10.44%
Market Cap2.92B Forward P/E3.70 EPS next Y3.54 Insider Trans-0.68% Shs Float221.72M Perf Month16.31%
Income-3300.50M PEG- EPS next Q0.73 Inst Own99.20% Short Float10.17% Perf Quarter-1.28%
Sales4.08B P/S0.71 EPS this Y-850.90% Inst Trans-0.78% Short Ratio2.46 Perf Half Y-21.44%
Book/sh9.81 P/B1.34 EPS next Y-1.94% ROA-21.50% Target Price15.81 Perf Year-13.80%
Cash/sh- P/C- EPS next 5Y-6.49% ROE-78.80% 52W Range9.70 - 24.93 Perf YTD-20.34%
Dividend- P/FCF5.07 EPS past 5Y-61.60% ROI-25.30% 52W High-47.37% Beta0.53
Dividend %- Quick Ratio0.90 Sales past 5Y9.70% Gross Margin36.00% 52W Low35.26% ATR0.65
Employees4894 Current Ratio1.10 Sales Q/Q7.70% Oper. Margin-84.40% RSI (14)59.73 Volatility4.91% 5.52%
OptionableYes Debt/Eq3.77 EPS Q/Q-85.80% Profit Margin-82.90% Rel Volume0.43 Prev Close12.89
ShortableYes LT Debt/Eq3.76 EarningsMay 09 BMO Payout- Avg Volume9.19M Price13.12
Recom2.60 SMA206.90% SMA5015.31% SMA200-15.77% Volume3,907,340 Change1.78%
May-25-17Reiterated Mizuho Buy $18 → $19
Feb-22-17Initiated Canaccord Genuity Hold $14
Jan-31-17Reiterated Mizuho Buy $25 → $15
Jan-20-17Downgrade JP Morgan Overweight → Neutral
Jan-05-17Downgrade Citigroup Buy → Neutral
Dec-07-16Resumed Oppenheimer Perform
Nov-11-16Reiterated Mizuho Buy $29 → $25
Nov-10-16Upgrade Susquehanna Neutral → Positive
Nov-09-16Reiterated RBC Capital Mkts Outperform $26 → $21
Sep-29-16Upgrade Northland Capital Market Perform → Outperform
Aug-12-16Upgrade Mizuho Neutral → Buy $16 → $29
Jun-13-16Upgrade Mizuho Underperform → Neutral $13 → $16
Jun-06-16Initiated Goldman Neutral $20
May-18-16Reiterated Stifel Buy $75 → $25
May-09-16Reiterated Deutsche Bank Buy $61 → $31
May-06-16Reiterated Stifel Buy $90 → $75
May-06-16Reiterated Barclays Equal Weight $37 → $28
May-06-16Downgrade Piper Jaffray Overweight → Neutral
May-06-16Downgrade Mizuho Neutral → Underperform $42 → $13
May-06-16Downgrade Leerink Partners Outperform → Mkt Perform
May-26-17 07:30AM  Endo to Present at Goldman Sachs 38th Annual Global Healthcare Conference CNW Group
May-25-17 04:10PM  Teva Pharma, Eagle Pharma, Depomed Among Slew Getting Price Haircuts Investor's Business Daily
May-24-17 08:00AM  Today's Research Reports on Stocks to Watch: Endo International and Helios and Matheson Analytics Accesswire
May-19-17 01:33PM  Valeant Pharmaceuticals: IntriguedReally? Barrons.com
May-16-17 03:30PM  BDSI CEO on Belbuca revenue potential: We're on an upward trend American City Business Journals
May-15-17 08:59PM  New York county sues Purdue, J&J over opioid marketing Reuters
05:46PM  New York county sues Purdue, J&J over opioid marketing Reuters
01:00PM  These Stocks Show Change of Direction TheStreet.com
May-13-17 05:11PM  Edited Transcript of ENDP earnings conference call or presentation 9-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-10-17 08:00AM  Today's Research Reports on Stocks to Watch: Endo International and Valeant Pharmaceuticals Accesswire
May-09-17 09:06PM  Edited Transcript of ENDP earnings conference call or presentation 9-May-17 12:30pm GMT Thomson Reuters StreetEvents +18.16%
02:07PM  Endo (ENDP) Beats on Q1 Earnings, Reaffirms '17 Guidance Zacks
01:02PM  Here's What's Behind Endo International plc's Rally Today Motley Fool
08:54AM  Endo (ENDP) Q1 Earnings Beat Estimates, Revenues in Line Zacks
07:45AM  Investor Network: Endo International Plc to Host Earnings Call Accesswire
07:25AM  Endo reports 1Q loss Associated Press
07:00AM  Endo profit beats on strong sales of generic drugs Reuters
06:40AM  Endo posts 7.7 percent rise in quarterly revenue Reuters
06:30AM  Endo Reports First-Quarter 2017 Financial Results PR Newswire
May-08-17 05:24PM  4 Drug Stocks Poised to Beat this Earnings Season Zacks
May-06-17 02:27AM  [$$] Suits Dog Guggenheim Chief Barrons.com
May-04-17 05:32PM  Is Endo (ENDP) Poised for a Beat This Earnings Season? Zacks
May-03-17 02:14PM  Generics Drop Across Board as DOJ Inquiry Expands TheStreet.com -6.52%
08:53AM  Perrigo Stock Sliding on DOJ Search TheStreet.com
May-02-17 05:14PM  Endo International Plc Value Analysis (NASDAQ:ENDP) : May 2, 2017 Capital Cube
May-01-17 08:10AM  Endo International Plc breached its 50 day moving average in a Bullish Manner : ENDP-US : May 1, 2017 Capital Cube
07:30AM  Endo to Present at UBS Global Healthcare Conference CNW Group
Apr-27-17 06:02PM  These are the only 9 stocks Morningstar is fully bullish on MarketWatch
Apr-26-17 08:28PM  There are only nine five-star U.S. stocks, but dont panic: Morningstar CEO MarketWatch
Apr-25-17 07:30AM  Endo to Announce First-Quarter 2017 Financial Results PR Newswire
Apr-20-17 09:44AM  Biotech Movers: Organovo, Endo, Omeros TheStreet.com
Apr-13-17 05:51PM  Which Drugmakers Will Rock The Sector In Q1? Investor's Business Daily
12:05PM  Endo International plc -- Moody's rates Endo's new secured notes Ba2 Moody's
08:43AM  Are Options Traders Betting on a Big Move in Endo International (ENDP) Stock? Zacks
Apr-12-17 07:19PM  Endo International plc Announces Pricing of Private Offering of Senior Secured Notes PR Newswire
07:19PM  Endo International plc Announces Pricing of Private Offering of Senior Secured Notes CNW Group
Apr-11-17 05:46PM  Endo (ENDP) Reports Preliminary Results for First Quarter Zacks -9.35%
04:41PM  Why AmTrust Financial Services, Endo International, and Hub Group Slumped Today Motley Fool
Apr-10-17 06:23PM  Endo Finance LLC -- Moody's rates Endo's new secured notes Ba2 Moody's
01:27PM  Endo International plc Announces Proposed Private Offering of Senior Secured Notes PR Newswire
01:27PM  Endo International plc Announces Proposed Private Offering of Senior Secured Notes CNW Group
08:14AM  Endo International Plc breached its 50 day moving average in a Bullish Manner : ENDP-US : April 10, 2017 Capital Cube
Apr-07-17 09:25AM  Endo international, AngioDynamics Lead Biotech Movers TheStreet.com
Apr-05-17 07:30AM  Endo International plc Announces Plan to Refinance Existing Credit Agreement PR Newswire
07:30AM  Endo International plc Announces Plan to Refinance Existing Credit Agreement
Apr-04-17 07:00PM  Endo Luxembourg Finance I Company S.a.r.l. -- Moody's downgrades Endo's CFR to B2; assigns Ba2 to new secured debt Moody's
07:00PM  Endo Luxembourg Finance I Company S.a.r.l. -- Moody's downgrades Endo's CFR to B2; assigns Ba2 to new secured debt
Mar-31-17 03:20AM  Why Is Endo (ENDP) Down 10.6% Since the Last Earnings Report? Zacks
03:20AM  Why Is Endo (ENDP) Down 10.6% Since the Last Earnings Report?
Mar-30-17 04:59PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Change in Directors or Principal Officers
Mar-28-17 05:51PM  Will Endo's Troubles Continue to Dent Performance in 2017? Zacks
05:51PM  Will Endo's Troubles Continue to Dent Performance in 2017?
05:51PM  Will Endo's Troubles Continue to Dent Performance in 2017? at Investopedia
11:11AM  VIVUS to Regain Commercial Rights for Stendra from Sanofi
Mar-27-17 01:32PM  Shire: Can It Pay Down Debt? Barrons.com +5.32%
01:32PM  Shire: Can It Pay Down Debt? at Barrons.com
Mar-22-17 09:23AM  Billionaires' Worst Healthcare Stock Picks for 2017 (So Far) Motley Fool
09:23AM  Billionaires' Worst Healthcare Stock Picks for 2017 (So Far) at Motley Fool
Mar-20-17 10:10AM  BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet Zacks
10:10AM  BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet
Mar-17-17 09:27AM  Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Expanded
Mar-16-17 07:07PM  Endo's (ENDP) Opana ER's Risk Benefit Evaluated by FDA Zacks
07:07PM  Endo's (ENDP) Opana ER's Risk Benefit Evaluated by FDA
Mar-15-17 04:04PM  Frontier Communications, Rubicon Project Plunge into Wednesdays 52-Week Low Club 24/7 Wall St.
04:04PM  Frontier Communications, Rubicon Project Plunge into Wednesdays 52-Week Low Club
11:05AM  FDA panel: Endo opioid painkiller's risks outweigh its benefits at bizjournals.com
10:38AM  How Endo's FDA Committee Vote Affects Egalet
12:29AM  [$$] FDA Advisory Panel Says Benefits of Painkiller Opana ER No Longer Outweigh Risks at The Wall Street Journal
Mar-14-17 08:48PM  Endo Statement On FDA Advisory Committees' Vote Related To OPANA® ER PR Newswire
08:28PM  FDA deals blow to Endo over Opana ER Pain Med
05:35PM  Risks of Endo's opioid painkiller outweigh benefits: FDA panel
05:29PM  [$$] FDA Panel: Painkiller Opana ER Benefits No Longer Outweigh Risks at The Wall Street Journal
04:02PM  FDA: Risk of Endo's opioid painkiller outweigh benefits
03:51PM  Risk of Endo's opioid painkiller outweigh benefits: FDA Panel
Mar-09-17 09:05AM  New Strong Sell Stocks for March 9th
Mar-08-17 08:37AM  Why Endo International (ENDP) Could Be Positioned for a Slump
08:29AM  Trumps Tweets Trigger a Sell-Off in the Healthcare Sector
Mar-07-17 01:04PM  ENDO INTERNATIONAL PLC Financials
12:51PM  Supernus, Valeant, Endo Stocks Lose Big After Trump Drug-Pricing Tweet
Mar-06-17 04:22PM  Has Biodelivery Sciences Finally Turned the Corner? at Motley Fool -6.94%
01:36PM  ETFs with exposure to Endo International Plc : March 6, 2017
Mar-03-17 04:30PM  Endo International plc To Delist Ordinary Shares From The Toronto Stock Exchange PR Newswire
Mar-02-17 12:16PM  Endo International Plc :ENDP-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017
Mar-01-17 02:23PM  ENDO INTERNATIONAL PLC Files SEC form 10-K, Annual Report -6.08%
09:47AM  Endo International Plc :ENDP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 1, 2017
Feb-28-17 05:09PM  Edited Transcript of ENDP earnings conference call or presentation 28-Feb-17 1:30pm GMT
12:17PM  Endo (ENDP) Beats on Q4 Earnings, Revenues; Guides Low
10:55AM  Endo profit, sales beat as the drugmaker enters transition phase
10:46AM  Aytu BioScience May Lead the Way in Low T
08:30AM  Endo International PLC Earnings Call scheduled for 8:30 am ET today
08:23AM  Endo (ENDP) Q4 Earnings & Revenues Beat Estimates
07:22AM  Endo reports 4Q loss
07:07AM  Q4 2016 Endo International PLC Earnings Release - Before Market Open
07:00AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
06:44AM  Endo Pharma revenue rises 15.6 pct
06:30AM  Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results PR Newswire
Feb-27-17 10:12AM  On Generic Drugs, Patent 'Death Squads' And The Oscars at Forbes
Feb-24-17 10:43PM  Endo Pharmaceuticals Inc. Issues Voluntary Nationwide Recall for One Lot of Edex® (alprostadil for injection) 10 mcg 2 Pack Carton Due to Potential Lack of Sterility Assurance PR Newswire
08:43AM  Implied Volatility Surging for Endo International (ENDP) Stock Options
Feb-23-17 05:57PM  Incyte, CBOE Holdings, Regency Centers Set to Join S&P 500; Others to Join S&P MidCap 400 PR Newswire
Endo International plc develops, manufactures, and distributes pharmaceutical products and devices worldwide. Its U.S. Generic Pharmaceuticals segment provides tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics, and transdermal patches for pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. The company's U.S. Branded Pharmaceuticals segment offers pain management products, such as Lidoderm, OPAN ER, Percocet, and Voltare Gel. This segment also provides Supprelin LA for central precocious puberty treatment; XIAFLEX for treating Peyronie's and Dupuytren's contracture diseases; Fortesta Gel for hypogonadism treatment; Testim Gel for the treatment of endogenous testosterone; Frova for migraine headaches; Valstar, a sterile solution for intravesical instillation of valrubicin; Vantas for the palliative treatment of prostate cancer; Aveed for the treatment of low testosterone; TESTOPEL, a long-acting implantable pellet; and NASCOBAL, a nasal spray. Its International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, and oncology; generic, branded generic, and over-the-counter products in the areas of dermatology and anti-infectives; and healthcare services, products, and solutions to hospitals, pharmacies, and practitioners, as well as for government healthcare programs. The company also provides injectables for the treatment of pain, anti-infectives, cardiovascular, and other therapeutics areas. It sells its branded pharmaceuticals and generics directly, as well as through wholesale drug distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Campanelli PaulPresident, CEOMar 16Buy10.722,30024,656207,120Mar 16 05:54 PM
Hutson Nancy JDirectorMar 09Sale10.825,32557,61731,252Mar 10 10:24 AM
KIMMEL ROGER HDirectorNov 15Sale17.387,000121,632188,000Nov 16 02:00 PM
KIMMEL ROGER HDirectorNov 15Sale17.387,000121,63268,362Nov 16 02:00 PM